Camptocormia in Parkinson's Disease

Objectives. Abnormalities of posture represent one of the main features of Parkinson's disease (PD). Among them, camptocormia has been considered as rare in PD. We investigated frequency and clinical features of camptocormia in PD patients. Methods. 153 PD patients (mean 68.5±10.7 years old, du...

Full description

Saved in:
Bibliographic Details
Main Authors: Kazuo Abe, Yutaka Uchida, Masaru Notani
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.4061/2010/267640
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561011235749888
author Kazuo Abe
Yutaka Uchida
Masaru Notani
author_facet Kazuo Abe
Yutaka Uchida
Masaru Notani
author_sort Kazuo Abe
collection DOAJ
description Objectives. Abnormalities of posture represent one of the main features of Parkinson's disease (PD). Among them, camptocormia has been considered as rare in PD. We investigated frequency and clinical features of camptocormia in PD patients. Methods. 153 PD patients (mean 68.5±10.7 years old, duration 5.9±2.4 years) outpatiently recruited. After neurologic examination, patients were rated on the Unified PD Rating Scale motor scale (UPDRS Part III), minimental state examination (MMSE). Also we evaluated patients with camptocormia by MRI. Of the 153 PD patients, 27 had camptocormia (mean age, 67.9±7.9 years old; disease duration, 6.1±3.9 years). For further evaluation, we recruited age- and sex-matched 27 PD patients without camptocormia (11 men and 16 women; mean age ±SD, 69.2±10.1 years, duration 6.0±2.7 years) These selected 54 patients completed several self-assessments. Lumbar and thoracic paraspinal muscles were studied by EMG. Results. There were no significant differences in age, duration, severity, and drug dose between patients with and without camptocormia. Analysis of NMSS subitems indicated that PD patients tended to show lower scores for sleep/fatigue, attention/memory, and miscellaneous items. Conclusions. We found significant differences concerning nonmotor signs and symptoms evaluated by FAB, PDQ-8, FSQ, VAS-F, and NMSS between patients with and without camptocormia. Our findings indicate that camptocormia is a relatively common sign in PD and that patients with camptocormia scores on the PDQ-8 compared with PD patients without camptocormia. This suggests that improvements in camptocormia of PD patients may improve their QOL.
format Article
id doaj-art-46e8847efee44ecfad9fdcf9b9900742
institution Kabale University
issn 2042-0080
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Parkinson's Disease
spelling doaj-art-46e8847efee44ecfad9fdcf9b99007422025-02-03T01:26:08ZengWileyParkinson's Disease2042-00802010-01-01201010.4061/2010/267640267640Camptocormia in Parkinson's DiseaseKazuo Abe0Yutaka Uchida1Masaru Notani2Department of Nursing and Rehabilitation, Konan Women's University, Kobe 657-0001, JapanDepartment of Neurology and Rehabilitation Center, Konan Hospital, Kobe 658-0064, JapanGaracia Hospital, Rehabilitation Center, Yokosuka 562-8567, JapanObjectives. Abnormalities of posture represent one of the main features of Parkinson's disease (PD). Among them, camptocormia has been considered as rare in PD. We investigated frequency and clinical features of camptocormia in PD patients. Methods. 153 PD patients (mean 68.5±10.7 years old, duration 5.9±2.4 years) outpatiently recruited. After neurologic examination, patients were rated on the Unified PD Rating Scale motor scale (UPDRS Part III), minimental state examination (MMSE). Also we evaluated patients with camptocormia by MRI. Of the 153 PD patients, 27 had camptocormia (mean age, 67.9±7.9 years old; disease duration, 6.1±3.9 years). For further evaluation, we recruited age- and sex-matched 27 PD patients without camptocormia (11 men and 16 women; mean age ±SD, 69.2±10.1 years, duration 6.0±2.7 years) These selected 54 patients completed several self-assessments. Lumbar and thoracic paraspinal muscles were studied by EMG. Results. There were no significant differences in age, duration, severity, and drug dose between patients with and without camptocormia. Analysis of NMSS subitems indicated that PD patients tended to show lower scores for sleep/fatigue, attention/memory, and miscellaneous items. Conclusions. We found significant differences concerning nonmotor signs and symptoms evaluated by FAB, PDQ-8, FSQ, VAS-F, and NMSS between patients with and without camptocormia. Our findings indicate that camptocormia is a relatively common sign in PD and that patients with camptocormia scores on the PDQ-8 compared with PD patients without camptocormia. This suggests that improvements in camptocormia of PD patients may improve their QOL.http://dx.doi.org/10.4061/2010/267640
spellingShingle Kazuo Abe
Yutaka Uchida
Masaru Notani
Camptocormia in Parkinson's Disease
Parkinson's Disease
title Camptocormia in Parkinson's Disease
title_full Camptocormia in Parkinson's Disease
title_fullStr Camptocormia in Parkinson's Disease
title_full_unstemmed Camptocormia in Parkinson's Disease
title_short Camptocormia in Parkinson's Disease
title_sort camptocormia in parkinson s disease
url http://dx.doi.org/10.4061/2010/267640
work_keys_str_mv AT kazuoabe camptocormiainparkinsonsdisease
AT yutakauchida camptocormiainparkinsonsdisease
AT masarunotani camptocormiainparkinsonsdisease